Acetylcysteine Inhalant
NDC Package 55154-5730-5
Package Information
Acetylcysteine inhalants is when inhaled by mouth, acetylcysteine is used to help thin and loosen mucus in the airways due to certain lung diseases (such as emphysema, bronchitis, cystic fibrosis, pneumonia). This formulation utilizes a inhalant delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-5730 and is authorized under FDA application ANDA072489.
Identification & Billing
- RxCUI: 307718 - acetylcysteine 10 % Inhalation Solution
- RxCUI: 307718 - acetylcysteine 100 MG/ML Inhalation Solution
- RxCUI: 307719 - acetylcysteine 20 % Inhalation Solution
- RxCUI: 307719 - acetylcysteine 200 MG/ML Inhalation Solution
Clinical Specifications
- Antidote - [EPC] (Established Pharmacologic Class)
- Antidote for Acetaminophen Overdose - [EPC] (Established Pharmacologic Class)
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Increased Glutathione Concentration - [PE] (Physiologic Effect)
- Mucolytic - [EPC] (Established Pharmacologic Class)
- Reduction Activity - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 55154 - Cardinal Health 107, Llc
- 55154-5730 - Acetylcysteine
- 55154-5730-5 - 5 VIAL, GLASS in 1 BAG / 4 mL in 1 VIAL, GLASS
- 55154-5730 - Acetylcysteine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55154-5730-5 identifies a specific commercial package of 5 vial, glass in 1 bag / 4 ml in 1 vial, glass of Acetylcysteine, a human prescription drug labeled by Cardinal Health 107, Llc. This inhalant is formulated for respiratory (inhalation) use and contains acetylcysteine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on May 06, 2011. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
When inhaled by mouth, acetylcysteine is used to help thin and loosen mucus in the airways due to certain lung diseases (such as emphysema, bronchitis, cystic fibrosis, pneumonia). This effect helps you to clear the mucus from your lungs so that you can breathe easier. When taken by mouth, acetylcysteine is used to prevent liver damage from acetaminophen overdose.
How is this Cardinal Health 107, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154573005. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.